by Admin | Jun 9, 2022 | CME INDIA Repository
CME INDIA Presentation by Dr. N. K. Singh, MD, FICP, Director, Diabetes and Heart Research Centre, Dhanbad, Jharkhand, India. Editor, www.cmeindia.in. Based on the presentation at Diabetes India Conference 2022. Amazing changes in heart of SGLT2-Inhibitor treated... 
by Admin | Mar 2, 2022 | CME INDIA Repository
CME INDIA Presentation by Dr. N.K. Singh, MD, FICP, Director, Diabetes and Heart Research Centre, Dhanbad, Jharkhand, India. Editor, www.cmeindia.in. Adding a new patient profile in whom we can start empagliflozin in hospital. Starting SGLT2 inhibitors as soon as in... 
by Admin | Sep 15, 2021 | CME INDIA Repository
CME INDIA Presentation by Dr. N. K. Singh, MD, FICP, Director – Diabetes and Heart Research Centre, Dhanbad; Editor – CME INDIA. Black hole of cardiology, the HFpEF gets an efficacious, disease modifying treatment – NNT (Number needed to treat) of 9....